# OnCo record prevention-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/roadmaps/prevention-roadmap/>
  a schema:CreativeWork ;
  onco:kind "roadmap" ;
  schema:identifier "prevention-roadmap" ;
  schema:name "Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers"@en ;
  schema:description "About four in ten cancers could be prevented with tools that already exist: vaccines against the viruses that cause them, tobacco and alcohol control, weight, aspirin for the right people, and finding the families who carry a high-risk gene. The roadmap is mostly about deployment, with interception vaccines as the long-range bet."@en ;
  schema:url <https://onco.cc/roadmaps/prevention-roadmap/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.who.int/initiatives/cervical-cancer-elimination-initiative>, <https://doi.org/10.1056/EVIDoa2100056>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2504650> ;
  onco:related <https://onco.cc/collections/uk-biobank/>, <https://onco.cc/roadmaps/cure-paths/>, <https://onco.cc/roadmaps/early-detection-roadmap/>, <https://onco.cc/roadmaps/nutrition-lifestyle-roadmap/>, <https://onco.cc/ideas/idea-prev-hpv-single-dose-switch-catchup/>, <https://onco.cc/ideas/idea-prev-hpv-self-sampling-mailed-default/>, <https://onco.cc/ideas/idea-prev-hpv-male-catchup-oropharynx/>, <https://onco.cc/ideas/idea-single-dose-hpv-self-sampling-elimination/>, <https://onco.cc/ideas/idea-prev-hbv-treat-all-hcc/>, <https://onco.cc/ideas/idea-prev-hpylori-family-test-and-treat/>, <https://onco.cc/ideas/idea-moon-eliminate-infection-cancers/>, <https://onco.cc/ideas/idea-prev-smokefree-generation-evaluation/>, <https://onco.cc/ideas/idea-prev-cytisine-essential-medicine/>, <https://onco.cc/ideas/idea-prev-alcohol-cancer-warning-labels/>, <https://onco.cc/ideas/idea-prev-glp1-cancer-prevention-rct/>, <https://onco.cc/ideas/idea-reg-aspirin-pik3ca-implementation/>, <https://onco.cc/ideas/idea-prev-lynch-aspirin-implementation/>, <https://onco.cc/ideas/idea-prev-low-dose-tamoxifen-uptake/>, <https://onco.cc/ideas/idea-prev-opportunistic-salpingectomy-default/>, <https://onco.cc/ideas/idea-moon-population-germline-screening/>, <https://onco.cc/ideas/idea-prev-population-germline-screening-at-30/>, <https://onco.cc/ideas/idea-prev-cascade-direct-contact-relatives/>, <https://onco.cc/ideas/idea-prev-reflex-germline-testing/>, <https://onco.cc/ideas/idea-prev-prs-screening-start-age/>, <https://onco.cc/ideas/idea-prev-prs-ancestry-portability-standard/>, <https://onco.cc/ideas/idea-interception-vaccines/>, <https://onco.cc/ideas/idea-prev-lynch-frameshift-vaccine-rct/>, <https://onco.cc/ideas/idea-moon-lynch-vaccine-phase3/>, <https://onco.cc/ideas/idea-prev-brca1-denosumab-prevention/>, <https://onco.cc/ideas/idea-prev-chemoprevention-master-protocol/>, <https://onco.cc/ideas/idea-prev-precursor-endpoints-for-approval/>, <https://onco.cc/ideas/idea-fund-social-impact-bonds-prevention/>, <https://onco.cc/ideas/idea-prev-pharmacy-prevention-hub/>, <https://onco.cc/ideas/idea-moon-hpv-vaccine-confidence/>, <https://onco.cc/ideas/idea-prev-radon-testing-at-property-sale/>, <https://onco.cc/roadmaps/lung-cancer-evidence-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/> ;
  onco:sections <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/hpv-testing/>, <https://onco.cc/technologies/precancer-ablation/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/technologies/aspirin-cancer-prevention/>, <https://onco.cc/technologies/risk-reducing-salpingectomy/>, <https://onco.cc/technologies/polygenic-risk-scores/>, <https://onco.cc/technologies/interception-vaccination/>, <https://onco.cc/technologies/shared-antigen-vaccine/>, <https://onco.cc/technologies/alcohol-reduction-labelling/>, <https://onco.cc/technologies/smoking-cessation-after-diagnosis/>, <https://onco.cc/technologies/glp1-agonists-cancer-risk/>, <https://onco.cc/technologies/bariatric-surgery-cancer-incidence/>, <https://onco.cc/technologies/hcc-surveillance/>, <https://onco.cc/technologies/colorectal-screening/>, <https://onco.cc/technologies/low-dose-ct-screening/> ;
  onco:drugs <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/drugs/cervavac/>, <https://onco.cc/drugs/tamoxifen/> ;
  onco:companies <https://onco.cc/companies/serum-institute-of-india/>, <https://onco.cc/companies/myriad-genetics/> ;
  onco:institutions <https://onco.cc/institutions/who/>, <https://onco.cc/institutions/iarc/>, <https://onco.cc/institutions/icmr-nicpr/> ;
  onco:terms <https://onco.cc/terms/risk-factor/>, <https://onco.cc/terms/obesity-related-cancers/> ;
  onco:trials <https://onco.cc/trials/ken-she/>, <https://onco.cc/trials/iarc-india-hpv-dose-study/>, <https://onco.cc/trials/osmanabad-hpv-screening/>, <https://onco.cc/trials/alascca/>, <https://onco.cc/trials/add-aspirin/>, <https://onco.cc/trials/aspree/>, <https://onco.cc/trials/nordicc/>, <https://onco.cc/trials/nlst-nelson/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-prevention-adoption/>, <https://onco.cc/bottlenecks/b-hereditary-risk/>, <https://onco.cc/bottlenecks/b-funding-allocation/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-overdiagnosis/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-barnabas-nejm-evid/> .